HMGB1 and neoplasm: Additionally, TDEs carrying high mobility group protein B1 (HMGB1) have been reported to trigger the differentiation of TIM-1+ Bregs, which suppress the cytotoxic activity of CD8+ T cells and support tumor survival and metastasis [34,35,36,37,38].